Paying users zone. Data is covered by .

  • Get to Eli Lilly & Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

 

$15.99


Ratios (Summary)

Eli Lilly & Co., long-term (investment) activity ratios

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net fixed asset turnover
Total asset turnover
Equity turnover

Source: Based on data from Eli Lilly & Co. Annual Reports

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Eli Lilly & Co.'s net fixed asset turnover improved from 2015 to 2016 and from 2016 to 2017.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Eli Lilly & Co.'s total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017.
Equity turnover An activity ratio calculated as total revenue divided by shareholders' equity. Eli Lilly & Co.'s equity turnover improved from 2015 to 2016 and from 2016 to 2017.

Top


Net Fixed Asset Turnover

Eli Lilly & Co., net fixed asset turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Revenue
Property and equipment, net
Ratio
Net fixed asset turnover1
Benchmarks
Net Fixed Asset Turnover, Competitors
Abbott Laboratories
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Net Fixed Asset Turnover, Sector
Pharmaceuticals & Biotechnology
Net Fixed Asset Turnover, Industry
Health Care

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 Net fixed asset turnover = Revenue ÷ Property and equipment, net
= ÷ =

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Eli Lilly & Co.'s net fixed asset turnover improved from 2015 to 2016 and from 2016 to 2017.

Top


Total Asset Turnover

Eli Lilly & Co., total asset turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Revenue
Total assets
Ratio
Total asset turnover1
Benchmarks
Total Asset Turnover, Competitors
Abbott Laboratories
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Total Asset Turnover, Sector
Pharmaceuticals & Biotechnology
Total Asset Turnover, Industry
Health Care

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 Total asset turnover = Revenue ÷ Total assets
= ÷ =

Ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Eli Lilly & Co.'s total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

Top


Equity Turnover

Eli Lilly & Co., equity turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Revenue
Total Eli Lilly and Company shareholders' equity
Ratio
Equity turnover1
Benchmarks
Equity Turnover, Competitors
Abbott Laboratories
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Equity Turnover, Sector
Pharmaceuticals & Biotechnology
Equity Turnover, Industry
Health Care

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 Equity turnover = Revenue ÷ Total Eli Lilly and Company shareholders' equity
= ÷ =

Ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders' equity. Eli Lilly & Co.'s equity turnover improved from 2015 to 2016 and from 2016 to 2017.

Top